Literature DB >> 1733191

Rapid growth of leiomyoma in patient receiving tamoxifen.

P V Dilts1, M P Hopkins, A E Chang, R L Cody.   

Abstract

A 49-year-old patient with breast cancer had a leiomyoma that rapidly enlarged shortly after she started therapy with tamoxifen. Exploratory laparotomy was necessary to confirm the diagnosis. The rapid growth may have resulted from the estrogen agonist properties of tamoxifen or alternatively by ovarian stimulation resulting in endogenous estrogen production.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1733191     DOI: 10.1016/0002-9378(92)91854-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  11 in total

Review 1.  Effect of SERMs on the uterus and menopausal symptoms.

Authors:  M Dören
Journal:  J Endocrinol Invest       Date:  1999-09       Impact factor: 4.256

2.  Leiomyomatosis peritonealis disseminata in association with Currarino syndrome?

Authors:  Carmine Nappi; Attilio Di Spiezio Sardo; Vincenzo Dario Mandato; Giuseppe Bifulco; Elisa Merello; Antonio Savanelli; Chiara Mignogna; Valeria Capra; Maurizio Guida
Journal:  BMC Cancer       Date:  2006-05-10       Impact factor: 4.430

Review 3.  A benefit-risk assessment of medical treatment for uterine leiomyomas.

Authors:  Vincenzo De Leo; Giuseppe Morgante; Antonio La Marca; Maria Concetta Musacchio; Massimo Sorace; Chiara Cavicchioli; Felice Petraglia
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  The effect of tamoxifen on the endometrium.

Authors:  B Uziely; A Lewin; G Brufman; D Dorembus; S Mor-Yosef
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

Review 5.  Gynaecologic effects of tamoxifen.

Authors:  D Y Kuo; C D Runowicz
Journal:  Med Oncol       Date:  1995-06       Impact factor: 3.064

Review 6.  What do we know and what don't we know about tamoxifen in the human uterus.

Authors:  A Friedl; V C Jordan
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

Review 7.  Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer.

Authors:  V C Jordan
Journal:  Br J Pharmacol       Date:  1993-10       Impact factor: 8.739

8.  Tumorigenic effects of tamoxifen on the female genital tract.

Authors:  Kaei Nasu; Noriyuki Takai; Masakazu Nishida; Hisashi Narahara
Journal:  Clin Med Pathol       Date:  2008-03-01

9.  Tamoxifen treatment in premenopausal breast cancer patients may be associated with ovarian overstimulation, cystic formations and fibroid overgrowth.

Authors:  I Cohen; D J Rosen; M Altaras; Y Beyth; J Shapira; D Yigael
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

Review 10.  Etiology and pathogenesis of uterine leiomyomas: a review.

Authors:  Gordon P Flake; Janet Andersen; Darlene Dixon
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.